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ABSTRACT Visualization of the vascular systems of organs or of small animals is important for
an assessment of basic physiological conditions, especially in studies that involve genetically manip-
ulated mice. For a detailed morphological analysis of the vascular tree, it is necessary to demon-
strate the system in its entirety. In this study, we present a new lipophilic contrast agent, Angioﬁl1,
for performing postmortem microangiography by using microcomputed tomography. The new con-
trast agent was tested in 10 wild-type mice. Imaging of the vascular system revealed vessels down
to the caliber of capillaries, and the digital three-dimensional data obtained from the scans allowed
for virtual cutting, ampliﬁcation, and scaling without destroying the sample. By use of computer
software, parameters such as vessel length and caliber could be quantiﬁed and remapped by color
coding onto the surface of the vascular system. The liquid Angioﬁl1 is easy to handle and highly
radio-opaque. Because of its lipophilic abilities, it is retained intravascularly, hence it facilitates vir-
tual vessel segmentation, and yields an enduring signal which is advantageous during repetitive
investigations, or if samples need to be transported from the site of preparation to the place of
actual analysis, respectively. These characteristics make Angioﬁl1 a promising novel contrast
agent; when combined with microcomputed tomography, it has the potential to turn into a powerful
method for rapid vascular phenotyping.
INTRODUCTION
Microangiography is an important tool for studying
the morphology of vessels down to the caliber of capilla-
ries. Studies of this kind are of great biological rele-
vance, since the vascular architecture of tissues and
organs reﬂects their physiological and metabolic prop-
erties. Filling vessels with radio-opaque materials is
an established procedure and many different com-
pounds have been reported so far (Speck, 2003).
Besides the well-known lyophilic salts, mostly barium
sulfate, iodized compounds have been historically used,
since iodine gives a high radiocontrast.
As an alternative to classical radio-opaque liquids or
emulsions, casting techniques are used (Gannon and
Hayat, 1978; Murakami, 1971; Nopanitaya et al.,
1979). There, blood vessels are ﬁlled with resins, e.g.,
methyl methacrylate, that polymerize within a given
timeframe. Upon removal of the biological tissue, a
rigid 3D framework is obtained that can be subse-
quently imaged by conventional microCT, synchrotron-
based CT, or confocal microscopy. Interestingly, high-
resolution imaging of casted structures has also been
achieved with scanning electron microscopy (SEM)
(Djonov and Burri, 2004; Hodde and Nowell, 1980;
Konerding, 1991; Konerding et al., 1995; Lametsch-
wandtner et al., 1990), although the latter reproduces
casts only in two dimensions. New polyurethane-based
materials for vascular corrosion casting were recently
introduced (Krucker et al., 2006), whereas the more
established methacrylate-based systems are on the
market for quite some years. Mueller and coworkers
have reported on ‘‘hierarchical microimaging’’ (Heinzer
et al., 2006), and their article summarizes well the
efforts in the ﬁeld of casting agents.
In practice, radiological microangiography (Barcley,
1947; Rubin, 1964) has permitted the visualization of
the microvascular systems of different organs (Barclay
and Bentley, 1949; Chang and Trembly, 1961) or ve-
nous ﬂaps (Imanishi et al., 1996), and a study on angio-
genesis has recently been presented (Djonov and
Makanya, 2005). The same methodology has also been
applied to investigate the vascular systems of entire
small organisms such as mice (Suo et al., 2007) or em-
bryonic chicken (Stoeter et al., 1980). With the former,
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which should be cited to refer to this work.
differences in the vascular systems of wild-type and ge-
netically manipulated mice were evaluated (Folkman,
1996).
We believe that the most promising imaging tech-
nique for viewing blood vessels in practice is microcom-
puted tomography, since it delivers true 3D informa-
tion and the corresponding data are digitally available
for further processing. It is beyond the scope of the
present report to summarize all the efforts and devel-
opments that have been made in the ﬁeld of microCT to
date. Nevertheless, the most important landmarks for
practical work should be seen in the introduction of
commercial desktop microCT scanners (Rueegsegger
et al., 1996; Sasov and van Dyck, 1997), and—more ori-
ented to basic research—in microtomography by using
synchrotron radiation (Bonse and Busch, 1996; Mar-
garitondo, 1988). For a good overview on basic litera-
ture dealing with microCT, see Engelke et al. (1999),
and for selected original publications, see among others
(Flannery et al., 1987; Hoddard et al., 1994). Because
microCT is nondestructive, the specimen can be used
for further experiments, e.g., it can be subjected to his-
tology after the measurements to gain complementary
information (Mueller et al., 2006).
The great beneﬁts that are gained from an analysis
of vascular systems by microCT have already been
demonstrated (Jorgensen et al., 1998; Karau et al.,
2001; Toyota et al., 2002). Various contrast agents have
been applied to enhance the vascular signals, and Hen-
kelman and coworkers have described putative advan-
tages and disadvantages for many of them (Marxen
et al., 2004). For postmortem angiography, our own
group has recently compared and reviewed several
methods and compounds (Grabherr et al., 2007). The
main problems encountered, especially with particle-
based contrast agents, are incomplete mixing, sedi-
mentation, and extravasation. The aim of this feasibil-
ity study was, therefore, to evaluate our in-house
developed contrast agent Angioﬁl1 for its performance
in the visualization of blood vessels in mice postmor-
tem. As we report here, the present method is straight-
forward and easy to use for accurately screening the
vascular system of rodents, e.g., knock-out mice, and




Angioﬁl1 has recently been developed at the Insti-
tute of Forensic Medicine in Bern, and its optimum
composition is the subject of ongoing research. It
mainly consists of an iodized oil (alkylesters of fatty
acids) and a diluting alkane. The ratio of the two com-
ponents can be adjusted to modify the viscosity of the
ﬁnal liquid. In our experiments, the iodized oil and the
diluent were combined at a ratio of 1:5, yielding a vis-
cosity of 3.4 mPa/s at 208C. In comparison, the viscosity
of blood is 4.3 mPa/s and the viscosity of water is
1 mPa/s (both at 218C), respectively.
Preparation of Samples
Ten 28- to 32-week old wild-type mice (Institute of
Experimental and Clinical Pharmacology and Toxicol-
ogy, Friedrich-Alexander-University Erlangen-Nurem-
berg, Germany) were used for this study. The animals
were housed and cared according to the guidelines of
the National Institute of Health. Anesthesia was
induced and maintained by an intraperitoneal injection
of ketamine (80–100 mg/kg of body weight) and xyla-
zine (10 mg/kg of body weight). Angioﬁl1 was injected
manually into the deeply anesthetized mice at room
temperature according to two different protocols (see
later).
Protocol 1. In the ﬁrst group of mice (n 5 5), the ab-
dominal cavity was dissected to visually control the
injection and to permit the outﬂow of blood from the
vascular system as it was replaced by the contrast
agent. A cannula (0.8 mm 3 25 mm, BD Venﬂon) was
inserted into either the right saphenous vein or the
inferior vena cava as a route of injection. Angioﬁl1 was
then injected manually under visual control until the
vascular system was cleared of blood, i.e., until the
ﬂuid leaving the vessels of the abdominal wall became
colorless. During the manual injection, the heart of the
anesthetized animal ceased to beat, typically in less
than 2 min.
Protocol 2. In the second group of mice (n 5 5), the
thoracic cavity was dissected and a cannula (0.4 mm 3
19 mm) was inserted into the left ventricle of the slowly
beating heart. One of the lobes of the liver was opened
to break the blood circuit. Initially, a 0.9% solution of
sodium chloride was injected into the vascular system
to clear it of from blood. Each animal was then per-
fused either with 4% paraformaldehyde or with ace-
tone to chemically ﬁx the tissue. Acampsia of the tail
and the hind limbs indicated that the tissue had been
sufﬁciently well ﬁxed. Angioﬁl1 was then injected
under visual control. Upon complete perfusion,
the main afferent and efferent vessels of the heart, the
liver, the lung, and the kidneys were ligated, and the
organs were removed. The individual lobes of the liver
and the lung were removed separately. Upon dissec-
tion, each organ or part of an organ was placed in a
Petri dish and immersed in 4% paraformaldehyde.
MicroCT Imaging and Data Processing
Protocol 1 (Mice 1–5). After removing the cannula,
each animal was placed on the table of an in vivo
microCT scanner (Tomoscope 30s, VAMP GmbH,
Erlangen, Germany). The body of the mouse was
scanned in two parts (head to liver and liver to pelvis,
respectively) using a tube voltage of 40 kV, a voxel di-
ameter of 40 lm, an acquisition time of 3 min, and a
radiation dose of 150 mGy.
Protocol 2 (Mice 6–10). The Petri dishes containing
the paraformaldehyde-immersed organs were placed
on a microCT scanner (high resolution ‘‘ForBild’’ scan-
ner, Institute of Medical Physics, FAU Erlangen-Nur-
emberg, Erlangen, Germany). Images were obtained
using a tube voltage of 40 kV, a voxel diameter of 15
lm, and an acquisition time of about 1 h. Some of the
samples were scanned using a voxel diameter of 10 lm
to further improve the resolution of the images.
The obtained scans according to the two protocols
were processed using a CT-workstation (Leonardo, Sie-
mens Erlangen, Germany). Both 2D and 3D recon-











partial body scans of mice 1–5 and building the 3D
models were done using the Amira software package
(Mercury Computer Systems) or the 3D-reconstruction
tools of the CT-workstation. Color coding of vessel cali-
ber and subsequent remapping onto the surface of the
3D model were applied according to our own software
code, as previously described (Gaudnek et al., 2005).
RESULTS
To evaluate a novel contrast agent, a straightforward
glimpse at contrasted versus uncontrasted sample tis-
sue may be the easiest start. This experiment is readily
performed as follows: reconstructed sagittal cross sec-
tions of a mouse were obtained without contrast agent
(Fig. 1a), and comparatively upon injection of Angioﬁl1
(Fig. 1b). In the latter, the heart and the vascular sys-
tem are clearly visible, whereas the scans without con-
trast agent do not show these distinct features.
Mice 1–5 were prepared according to protocol 1, and
the corresponding 3D reconstructions of their partial
body scans were merged to represent the entire vascu-
lar system (Fig. 2). After virtually cutting off the tho-
racic cage, an overview of the thoracic and abdominal
vessels was obtained. Thoracic and abdominal portions
of the aorta were demonstrated in their entirety. By
adjusting the viewing window on the workstation, the
main vessels of the vascular systems of different
organs could be visualized according to their caliber
size. Vascular branches of the liver could be seen to-
gether with their smaller ramiﬁcations. Vessels of the
spleen and the kidneys, as well as those of the mesen-
tery, were visible as well. The heart was completely
ﬁlled with the contrast agent, and the cardiac as well
as the pulmonary vessels were partially visible. Figure
2a shows the main vessels, whereas Figure 2b com-
prises also the medium-sized vessels. Figure 2c was
reconstructed in an enlarged viewing window which
also showed smaller periphery vessels.
Mice 6–10 were prepared according to protocol 2, and
high-resolution scans of individual organs revealed the
microvessels in great detail (Figs. 3–5). The small
arteries and veins, and even the capillaries of the lung
(Fig. 3), the kidneys (Fig. 4), and the liver (Fig. 5) were
visualized with a spatial resolution down to 15 lm. Re-
markable overviews of the main vessels of each organ
were obtained. The smallest vessels, such as those of
the glomeruli in the kidney, were also visible.
Since individual 2D cross sections were difﬁcult to
evaluate (data not shown), maximum intensity projec-
tions through all three dimensions were chosen and
gave a comprehensive overview of the complete data
set. The vascular system was backprojected from max-
imum intensity images and represented as an ‘‘iso-
surface’’ (Figs. 3c and 4c) rendered from images above
a given threshold. The production of such a surface
model is the ﬁrst segmentation step in the transfor-
mation of greyvalue-based images into geometric
descriptions of the vascular system. For this purpose,
we have used an Amira-based software code (earlier
developed in our group, see Gaudnek et al., 2005) that
executes each of the steps involved in digital vessel
reconstruction.
Fig. 1. Reconstructed sagittal cross section images of a mouse.
Without addition of a contrast agent (a), the heart and the vascular
system cannot be distinguished from other soft tissue. Upon injection
of Angioﬁl1 into the vascular system (b), the heart (H) and the vascu-
lar system (A, aorta) become clearly visible. The arrow indicates the
mesentery artery and the arrowhead indicates the carotid artery.
Fig. 2. 3D reconstruction from a microCT scan of a mouse. A part
of the skull is visible. The thoracic and abdominal vessels are ﬁlled
with Angioﬁl1. The thoracic cage has been virtually removed to facili-
tate an overview of the vascular system. Letters denominate the tho-
racic aorta (A) with its branches, the heart (H), vessels of the liver (L),
the kidneys (K), the spleen (S), and the mesentery (M). By adjusting
the viewing window of the workstation, it is possible to add the visual-
ization of different components of the vascular tree, starting from the
main vessels (a, top representation), through the medium-sized ones












For the high-resolution liver scan, vessel calibers
were quantiﬁed and remapped onto the surface of the
vascular system (Fig. 5). In the latter illustration, ves-
sels were color-coded according to their caliber, i.e.,
from blue via red to yellow, whereas blue represents
thinner (light blue: mean diameter up to 50 lm, dark
blue: mean diameter 100 lm) and red represents
thicker vessels (mean diameter 300 lm), respectively.
The thickest parts are marked in yellow (mean diame-
ter 400 lm).
DISCUSSION
Driven by our promising initial results with the
above data sets, we are conﬁdent that Angioﬁl1 has
Fig. 3. 3D models of high-resolution scans of a murine lung lobe
visualizing the vascular branches (a). After adjusting the viewing
window, much smaller branches of the vessels become visible (b). By
using ‘‘Amira,’’ the maximum intensity projections on the cube side
create an isosurface rendering of the vascular surface (c, yellow).
Fig. 4. 3D models of a high-resolution scan of a murine kidney vis-
ualizing the interlobular vessels in great detail (a). After adjusting
the viewing window, the smaller vessels of the cortex and those of the
glomeruli become included in the model (b). By using ‘‘Amira,’’ the
maximum intensity projections on the cube side create an isosurface
rendering of the vascular surface (c, yellow).
Fig. 5. 3D reconstruction of a high-resolution scan of part of a mu-
rine liver, representing the vascular tree with color coding of the vessel
caliber (increasing from blue via red to yellow, see color bar, numbers
are given in lm). Blue is used for thin vessels (light blue: mean diame-
ter up to 50 lm; dark blue: mean diameter 100 lm) and red is used for
thicker vessels (mean diameter 300 lm). The thickest parts are color
coded in yellow (mean diameter 400 lm). For the software code of the











the potential to become a valuable new contrast agent
for microangiography. Several points are supporting
this as follows:
First of all, Angioﬁl1 is a pure liquid, rather than a
particle-based compound. It thus circumvents all the
aspects of inhomogeneous mixing, i.e., originated from
sedimentation. The latter is known to be one of the
most stringent parameters for imaging blood vessels,
since incompletely mixed contrast emulsions can even-
tually lead to virtual disconnection of vessels in the
retrieved images (Mueller et al., 2006). A comparison
of Angioﬁl1 to more established barium sulfate stain-
ing is the subject of ongoing research. Preliminarily, we
have found that both contrast agents worked well for
lung vessel imaging in rodents; however, the size of the
barium sulfate particles strongly inﬂuenced inﬁltration
of the vessels, whereas Angioﬁl1 did not show such
phenomena (Dominietto et al., in press).
Secondly, Angioﬁl1 is based on an iodized oil which
is known to be retained by the vessels for a long time,
thus making it well suited for angiography. Pfeifer and
Zapata have addressed this issue in detail in macro-
scopic angiography (Pfeifer et al., 1947; Zapata et al.,
1989), and showed that iodized oils were retained in
the vessels for at least 72 h before being extravasated.
Comparative results were reported by Kan (Kan,
1996), i.e., after injecting an iodized oil into the liver,
he observed that it did not penetrate the surrounding
tissue. Our own group has carefully monitored the
intravascular remaining of oily liquids (Grabherr
et al., 2006, 2007) as follows: a probe that has been
chemically ﬁxed and ﬁlled with an oily contrast agent
remains stable for many days without leakage. In this
study, we scanned single organs more than 1 week af-
ter their perfusion with the contrast agent. No deterio-
ration in image quality was observed. In another study,
the time delay between sample preparation and CT
analysis was also on the order of several days, without
any implications on the experimental results (data not
shown). Consequently, organs can be perfused in one
laboratory and then sent elsewhere for microCT angi-
ography without the need to rush.
We want to point out that we manually injected the
contrast agent into the animals. Organs were perfused
manually, too, i.e., without a distinct perfusion control,
although at the beginning of our experiments we used
a perfusion pump. However, we very soon realized that
the effective pressure in the microcirculation depended
on many other factors than only perfusion pressure,
which was in agreement to earlier ﬁndings (Djonov
and Burri, 2004). In other words, the pump perfusion
pressure was not directly linked to the effective ‘‘real’’
pressure in the vascular tree. We thus abandoned the
use of a perfusion pump for this feasibility study.
It is important to note that a user can adapt Angio-
ﬁl1 according to his needs. The viscosity of Angioﬁl1
triggers the degree of embolization, i.e., it directly
determines which calibers of the vessels are ﬁlled at
what degree. Oils with a high viscosity lead to micro-
embolism and to an occlusion of the microcirculation
(Grabherr et al., 2006). But when the viscosity is low-
ered, e.g., by diluting the contrast agent, the oily liquid
also penetrates the smaller vessels. In our study, a vis-
cosity of 3.42 mPa/s (at 208C) was chosen, correspond-
ing to a volumetric 1:5 ratio of Angioﬁl1 versus dilut-
ing alkane. As a general recommendation for microan-
giography, the ratio should be between 1:3 and 1:5,
respectively. If only the main vessels, e.g., of a mouse
should be visualized, viscosity can be kept high. If the
small vessels and capillaries should be investigated,
the viscosity can be decreased by adding more diluent.
This leads to the possibility of caliber-dependent vessel
visualization.
Because of the high radio-opacity of the oily compo-
nent, injected vessels are sharply contrasted against a
signal-free background. This circumstance facilitates
the implementation of software solutions for an auto-
mated segmentation of the vessel tree and for the cal-
culation of quantitative data, such as vessel length,
caliber, and branching geometry. By drawing on the di-
versity of modern visualization techniques, it is possi-
ble to process the digital 3D data obtained from
microCT scans in many different ways. Parts of these
images can be virtually erased or ampliﬁed without
destroying the sample. Furthermore, upon scanning,
the chemically ﬁxed material is still amenable to a
histological analysis.
If an appropriate perfusion technique is employed,
then dynamic postmortem angiography becomes feasi-
ble (Grabherr et al., 2006). Using a perfusion pump, a
postmortem circulation can be established without risk
of edemae. Imaging at different time intervals permits
a sequential demonstration of different parts of the
vascular system, i.e., its arterial, parenchymatous, and
venous components.
As a next step, Angioﬁl1 will have to evidence its
comparability with respect to established casting meth-
ods. We want to point out, that Angioﬁl1 was not devel-
oped to replace casting techniques. Cast specimens
have several key advantages over classical contrast
agents. For example, casts can be subjected to SEM
analysis, which eventually allows for ﬁnal imaging at
resolutions down to several nanometers. Nevertheless,
casting often fails to maintain the entire vascular net-
work including capillaries, and cast specimens are typ-
ically prone to damage during their transport. It
should also not be ignored that casting is a time-con-
suming process that involves a polymerization step.
Here, impregnation of individual organs with Angio-
ﬁl1, or injecting the contrast agent into the animal,
may become a straightforward alternative route. To
learn more about the comparative performance of
Angioﬁl1 versus established casting agents, we have
recently started an international research study with
several vasculature imaging laboratories.
We have shown that our new contrast agent Angio-
ﬁl1 is able to contrast vasculature without the need of
time-consuming sample preparation. A set of 10 mice
have served for this microangiography postmortem.
Upon microCT scanning, the organs are readily avail-
able for further comparative analysis, e.g., histology.
With Angioﬁl1, the user can change the viscosity of the
contrast agent and thus trigger a caliber-dependent
visualization of the vessels. Since extravasation has
not been observed, sample preparation and subsequent
analysis can be largely separated in time. By using pro-
grams such as ‘‘Amira,’’ quantitative analysis of vessel
length and caliber is possible; such values can then be
color-encoded and remapped onto the surface of the











microCT represents a rapid and practicable method for
vascular phenotyping.
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